QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research
Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research
Discover AMSBIO’s optimized antibodies for stem cell research that offer high specificity, reproducibility, and validated purity for reliable results
The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease and therapeutic drug monitoring
Nuvec is N4 Pharma’s proprietary gene delivery system being developed to safely and effectively transport RNA therapies for cancer and other diseases
Due to its precise analytical performance, the HLC-723 GR01 enhances diagnostic confidence, supporting both high throughput and improved diabetes care
Introducing Cheetah™ FLEX and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerases for qPCR, PEA, and NGS-based PEA workflows
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
From synthetic biology to microbiome and food safety research, the QPix FLEX system gives researchers the power to accelerate discovery, reduce hands-on time, and streamline their entire microbial screening process
Designed to enable scientists to conduct small-scale experiments quickly and affordably
New data show Optimer delivery vehicle could be used in precision medicines across diverse fibrotic diseases
Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques
Successful project delivery of Optimer binders with proven function as vaccine adjuvants
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption
Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide
Combining Singleron’s innovation in single-cell technologies with Hamilton’s expertise in laboratory automation, Tensor streamlines the single-cell sequencing process
For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)
Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer
A high-performance, cost-effective brightfield-only solution with optional fluorescence upgrade, ideal for high-throughput labs seeking reproducibility and flexibility.
Incorporating a combination of advanced polymer sealing surfaces - Biotech Fluidics liquid distribution valves are completely biocompatible.